Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2013-06-15 16:49:50 UTC |
---|
Update Date | 2021-09-14 15:41:36 UTC |
---|
HMDB ID | HMDB0060562 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Captopril-cysteine disulfide |
---|
Description | Captopril-cysteine disulfide is a metabolite of captopril. Captopril is an angiotensin-converting enzyme inhibitor used for the treatment of hypertension and some types of congestive heart failure. Captopril was the first ACE inhibitor developed and was considered a breakthrough both because of its novel mechanism of action and also because of the revolutionary development process. Captopril is commonly marketed by Bristol-Myers Squibb under the trade name Capoten. (Wikipedia) |
---|
Structure | C[C@H](CSSC[C@H](N)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O InChI=1S/C12H20N2O5S2/c1-7(5-20-21-6-8(13)11(16)17)10(15)14-4-2-3-9(14)12(18)19/h7-9H,2-6,13H2,1H3,(H,16,17)(H,18,19)/t7-,8+,9+/m1/s1 |
---|
Synonyms | Value | Source |
---|
Captopril-cysteine disulphide | Generator | Captopril-L-cysteine | HMDB | Captopril-cysteine disulfide | MeSH |
|
---|
Chemical Formula | C12H20N2O5S2 |
---|
Average Molecular Weight | 336.428 |
---|
Monoisotopic Molecular Weight | 336.08136314 |
---|
IUPAC Name | (2S)-1-[(2S)-3-{[(2R)-2-amino-2-carboxyethyl]disulfanyl}-2-methylpropanoyl]pyrrolidine-2-carboxylic acid |
---|
Traditional Name | (2S)-1-[(2S)-3-{[(2R)-2-amino-2-carboxyethyl]disulfanyl}-2-methylpropanoyl]pyrrolidine-2-carboxylic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | C[C@H](CSSC[C@H](N)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O |
---|
InChI Identifier | InChI=1S/C12H20N2O5S2/c1-7(5-20-21-6-8(13)11(16)17)10(15)14-4-2-3-9(14)12(18)19/h7-9H,2-6,13H2,1H3,(H,16,17)(H,18,19)/t7-,8+,9+/m1/s1 |
---|
InChI Key | NEEBNBLVYKFVTK-VGMNWLOBSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as l-cysteine-s-conjugates. L-cysteine-S-conjugates are compounds containing L-cysteine where the thio-group is conjugated. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | L-cysteine-S-conjugates |
---|
Alternative Parents | |
---|
Substituents | - N-acyl-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- N-acyl-l-alpha-amino acid
- Proline or derivatives
- L-cysteine-s-conjugate
- L-alpha-amino acid
- Alpha-amino acid
- Pyrrolidine carboxylic acid or derivatives
- Pyrrolidine carboxylic acid
- N-acylpyrrolidine
- Dicarboxylic acid or derivatives
- Tertiary carboxylic acid amide
- Pyrrolidine
- Carboxamide group
- Amino acid
- Dialkyldisulfide
- Organic disulfide
- Carboxylic acid
- Azacycle
- Organoheterocyclic compound
- Sulfenyl compound
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Organosulfur compound
- Primary amine
- Primary aliphatic amine
- Amine
- Hydrocarbon derivative
- Organic oxide
- Carbonyl group
- Organopnictogen compound
- Organic oxygen compound
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Captopril-cysteine disulfide,1TMS,isomer #1 | C[C@H](CSSC[C@H](N)C(=O)O[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 2780.5 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,1TMS,isomer #2 | C[C@H](CSSC[C@H](N)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2814.7 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,1TMS,isomer #3 | C[C@H](CSSC[C@H](N[Si](C)(C)C)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O | 2814.4 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,2TMS,isomer #1 | C[C@H](CSSC[C@H](N)C(=O)O[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2800.5 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,2TMS,isomer #2 | C[C@H](CSSC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 2776.6 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,2TMS,isomer #3 | C[C@H](CSSC[C@H](N[Si](C)(C)C)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2807.9 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,2TMS,isomer #4 | C[C@H](CSSC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 2862.9 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,3TMS,isomer #1 | C[C@H](CSSC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2817.7 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,3TMS,isomer #1 | C[C@H](CSSC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2789.8 | Standard non polar | 33892256 | Captopril-cysteine disulfide,3TMS,isomer #1 | C[C@H](CSSC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 3690.2 | Standard polar | 33892256 | Captopril-cysteine disulfide,3TMS,isomer #2 | C[C@H](CSSC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 2850.0 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,3TMS,isomer #2 | C[C@H](CSSC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 2860.5 | Standard non polar | 33892256 | Captopril-cysteine disulfide,3TMS,isomer #2 | C[C@H](CSSC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 3860.2 | Standard polar | 33892256 | Captopril-cysteine disulfide,3TMS,isomer #3 | C[C@H](CSSC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2866.3 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,3TMS,isomer #3 | C[C@H](CSSC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2877.8 | Standard non polar | 33892256 | Captopril-cysteine disulfide,3TMS,isomer #3 | C[C@H](CSSC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 3802.9 | Standard polar | 33892256 | Captopril-cysteine disulfide,4TMS,isomer #1 | C[C@H](CSSC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2903.6 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,4TMS,isomer #1 | C[C@H](CSSC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2903.9 | Standard non polar | 33892256 | Captopril-cysteine disulfide,4TMS,isomer #1 | C[C@H](CSSC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 3373.7 | Standard polar | 33892256 | Captopril-cysteine disulfide,1TBDMS,isomer #1 | C[C@H](CSSC[C@H](N)C(=O)O[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 3028.5 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,1TBDMS,isomer #2 | C[C@H](CSSC[C@H](N)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 3053.9 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,1TBDMS,isomer #3 | C[C@H](CSSC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O | 3037.0 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,2TBDMS,isomer #1 | C[C@H](CSSC[C@H](N)C(=O)O[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 3266.7 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,2TBDMS,isomer #2 | C[C@H](CSSC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 3256.3 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,2TBDMS,isomer #3 | C[C@H](CSSC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 3274.9 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,2TBDMS,isomer #4 | C[C@H](CSSC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 3312.4 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,3TBDMS,isomer #1 | C[C@H](CSSC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 3481.4 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,3TBDMS,isomer #1 | C[C@H](CSSC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 3344.4 | Standard non polar | 33892256 | Captopril-cysteine disulfide,3TBDMS,isomer #1 | C[C@H](CSSC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 3800.4 | Standard polar | 33892256 | Captopril-cysteine disulfide,3TBDMS,isomer #2 | C[C@H](CSSC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 3564.6 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,3TBDMS,isomer #2 | C[C@H](CSSC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 3430.3 | Standard non polar | 33892256 | Captopril-cysteine disulfide,3TBDMS,isomer #2 | C[C@H](CSSC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 3899.0 | Standard polar | 33892256 | Captopril-cysteine disulfide,3TBDMS,isomer #3 | C[C@H](CSSC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 3572.3 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,3TBDMS,isomer #3 | C[C@H](CSSC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 3418.6 | Standard non polar | 33892256 | Captopril-cysteine disulfide,3TBDMS,isomer #3 | C[C@H](CSSC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 3862.4 | Standard polar | 33892256 | Captopril-cysteine disulfide,4TBDMS,isomer #1 | C[C@H](CSSC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 3817.8 | Semi standard non polar | 33892256 | Captopril-cysteine disulfide,4TBDMS,isomer #1 | C[C@H](CSSC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 3583.6 | Standard non polar | 33892256 | Captopril-cysteine disulfide,4TBDMS,isomer #1 | C[C@H](CSSC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 3639.8 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Captopril-cysteine disulfide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9420000000-1e9f91d2d1efa46fc197 | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Captopril-cysteine disulfide GC-MS (2 TMS) - 70eV, Positive | splash10-03xs-8983200000-7b08be09237de09d0fc1 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Captopril-cysteine disulfide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Captopril-cysteine disulfide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Captopril-cysteine disulfide 10V, Positive-QTOF | splash10-014u-1498000000-092d5ab2e49b20b5f7ba | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Captopril-cysteine disulfide 20V, Positive-QTOF | splash10-00r6-5891000000-ccb01429cf0929d73fe8 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Captopril-cysteine disulfide 40V, Positive-QTOF | splash10-00yu-9820000000-1e9aff4fc707a4070367 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Captopril-cysteine disulfide 10V, Negative-QTOF | splash10-0f79-1596000000-98258469d8e47f11a7aa | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Captopril-cysteine disulfide 20V, Negative-QTOF | splash10-00xr-2930000000-4af36cae664d5b02b289 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Captopril-cysteine disulfide 40V, Negative-QTOF | splash10-01w0-9520000000-32337ef8ce43c185983f | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Captopril-cysteine disulfide 10V, Positive-QTOF | splash10-000i-0109000000-2df803a6c88924bb358f | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Captopril-cysteine disulfide 20V, Positive-QTOF | splash10-00s9-2920000000-ca8c77c88ab583e51ddb | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Captopril-cysteine disulfide 40V, Positive-QTOF | splash10-00di-9400000000-9f652252926ed848c725 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Captopril-cysteine disulfide 10V, Negative-QTOF | splash10-000i-0129000000-8b03a122190b841d3d9e | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Captopril-cysteine disulfide 20V, Negative-QTOF | splash10-03k9-3910000000-8084e7c7b694112dcb05 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Captopril-cysteine disulfide 40V, Negative-QTOF | splash10-03di-5900000000-aef67a057426824ab06f | 2021-10-12 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|